Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Obesity 45Mucositis 29Neoplasms 23Sexual Dysfunction, Physiological 19Head and Neck Neoplasms 16Breast Neoplasms 16Opioid-Induced Constipation 12Dyspnea 11Constipation 11Pain 10Polycystic Ovary Syndrome 9Weight Loss 7Squamous Cell Carcinoma of Head and Neck 7Prostatic Neoplasms 7Motor Activity 7Diabetes Mellitus 7Cardiovascular Diseases 6Xerostomia 5Stomatitis 5Radiation Injuries 5Overweight 5Sedentary Behavior 4Endometrial Neoplasms 4Diabetes Mellitus, Type 2 4Colorectal Neoplasms 4Bronchiolitis Obliterans Syndrome 4Sexuality 3Salivary Gland Neoplasms 3Hypertension 3Fatty Liver 3

Interventions

Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Chemotherapy-Induced Peripheral Neuropathy × Other × Clear all
NCT05388058 2026-01-16

Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Mayo Clinic

Phase 2 Completed
40 enrolled 15 charts
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡